文献速递肝胆胰外科

机器人与腹腔镜远端胰腺切除术肿瘤学与手术结局比较:倾向性匹配分析

Comparing oncologic and surgical outcomes of robotic and laparoscopic distal pancreatectomy: a propensity-matched analysis.
PubMed 文献 · Surg Endosc · 2024-08-12

基于美国国家癌症数据库2010-2020年1537例接受微创远端胰腺切除术的胰腺导管腺癌患者,比较机器人与腹腔镜手术的短期结局。倾向性匹配后,机器人组中转开腹几率降低58%,但30天再入院率较高,两组住院时间、30天及90天死亡率无差异。技术肿瘤学结局(淋巴结清扫、切缘状态、辅助治疗启动)随机构手术量四分位数存在显著差异。

要点

  • 机器人远端胰腺切除术中转开腹率12.6%,显著低于腹腔镜的25.5%。
  • 两组住院时间、30天及90天死亡率无统计学差异,机器人组30天再入院率较高。
  • 淋巴结清扫、切缘状态及辅助治疗启动与机构微创手术量四分位数显著相关。

核心结论

  • 腹腔镜与机器人远端胰腺切除术具有相似的围手术期和术后手术及肿瘤学结局。
  • 腹腔镜队列中转开腹率更高。

研究设计与样本

  • 利用美国国家癌症数据库回顾性识别2010-2020年接受远端胰腺切除术的胰腺导管腺癌患者。
  • 共1537例接受微创远端胰腺切除术,其中腹腔镜74.4%(n=1144),机器人使用率从2010年8.7%增至十年后32.0%。
  • 倾向性评分匹配后698例腹腔镜患者与349例机器人患者配对,采用多因素逻辑回归评估机构手术量对结局的影响。

主要发现

  • 机器人组中转开腹几率较腹腔镜组低58%(12.6% vs 25.5%),技术肿瘤学结果无统计学显著差异。
  • 住院时间(OR=1.0[0.7-1.4])、30天死亡率(OR=0.5[0.2-2.0])及90天死亡率(OR=1.1[0.5-2.4])在两组间无差异。
  • 机器人组30天再入院率较高(OR=1.71[1.1-2.7])。
  • 基于微创远端胰腺切除术手术量四分位数的技术肿瘤学结局(淋巴结清扫、切缘状态、辅助治疗启动)存在统计学显著差异。

关键数值与推荐

  • 机器人组中转开腹率12.6%,腹腔镜组25.5%,机器人组中转开腹几率低58%。
  • 住院时间OR=1.0[0.7-1.4],30天死亡率OR=0.5[0.2-2.0],90天死亡率OR=1.1[0.5-2.4]。
  • 机器人组30天再入院OR=1.71[1.1-2.7]。

临床怎么用

  • 机器人远端胰腺切除术可降低中转开腹风险,但需关注30天再入院风险。
  • 机构微创手术量可能与技术肿瘤学结局相关,选择术式时需考虑机构经验。

局限性

  • 研究为基于国家数据库的回顾性分析,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The frequency of minimally invasive distal pancreatectomy is gradually exceeding that of the open approach. Our study aims to compare short-term outcomes of robotic (RDP) and laparoscopic (LDP) distal pancreatectomies for pancreatic ductal adenocarcinoma (PDAC) using a national database. METHODS: The National Cancer Database was utilized to identify patients with PDAC who underwent distal pancreatectomy from 2010-2020. Short-term technical and oncologic outcomes such as margin status and nodal harvest were included. Propensity-score matching (PSM) was performed comparing LDP and RDP cohorts. Multivariate logistic-regression models were then used to assess the impact of institutional volume on the MIDP surgical and technical oncologic outcomes. RESULTS: 1537 patients underwent MIDP with curative intent. Most cases were laparoscopic (74.4%, n = 1144), with a gradual increase in robotic utilization, from 8.7% in 2010 to 32.0% of MIDP cases ten years later. For PSM, 698 LDP patients were matched with 349 RDP. The odds of conversion to an open case were 58% less in RDP (12.6%) compared to LDP (25.5%) with no statistically significant difference in technical oncologic results. There was no difference in length of stay (OR = 1.0[0.7-1.4]), 30-day mortality (OR = 0.5[0.2-2.0]) or 90-day mortality (OR = 1.1[0.5-2.4]) between RDP and LDP, although there was a higher 30-day readmission rate with RDP (OR = 1.71[1.1-2.7]). There were statistically significant differences in technical oncologic outcomes (nodal harvest, margin status, initiation of adjuvant therapy) based on MIDP volume quartiles. CONCLUSION: Laparoscopic and robotic distal pancreatectomy have similar peri- and post-operative surgical and oncologic outcomes, with a higher rate of conversion to open in the laparoscopic cohort.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chang JH, Wehrle C, Woo K, et al. Comparing oncologic and surgical outcomes of robotic and laparoscopic distal pancreatectomy: a propensity-matched analysis. Surg Endosc. 2024. PMID: 39134718. doi:10.1007/s00464-024-11147-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。